Aditya Hadi Pratama · · 1 min readY Combinator-backed SG fertility startup bags $5.1m funding (Updated)
Update (May 1o, 10:45 a.m. SGT): This article was updated after the company clarify the participating investor in this round.
Hannah Life, a Singapore-based healthtech firm, has raised over US$5.1 million in a pre-series A funding round led by Monk’s Hill Ventures, with participation from Golden Gate Ventures, Anthro Ventures, and Jack Wang.
Hannah Life’s team / Photo credit: Hannah Life
Founded in 2019, Hannah Life provides home-based fertility health solutions such as hormone tests and offers a sperm guide device, which helps deposit sperm onto the cervical opening to optimize chances of fertilization.
The company said it has launched its products in Singapore and the United Kingdom. Since its commercial launch in August last year, its revenue has grown more than 4x every quarter.
Hannah Life was founded by Prusothman Sina Raja and Benjamin Tee, and has raised seed funding from Y Combinator in 2020. The duo previously started another healthtech startup called Privi Medical, which was eventually sold to IPO-bound Hemo Bioengineering.
Hannah Life plans to use the fresh funding to hire more employees and increase sales and marketing efforts in the US and Europe.
See also: Series SEA: Who’s investing in the region’s health startups?
Editing by Deepti Sri and Jaclyn Tiu
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
